Pub. Date : 2019 Aug
PMID : 31253572
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. | iph4102 | killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 | Homo sapiens |
| 2 | BACKGROUND: IPH4102 is a first-in-class monoclonal antibody targeting KIR3DL2, a cell surface protein that is expressed in cutaneous T-cell lymphoma, and predominantly in its leukaemic form, Sezary syndrome. | iph4102 | killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 | Homo sapiens |